Bipartisan group of 23 state AGs joins call for unrestricted coverage of Alzheimer’s treatments
By
Kimberly Bonvissuto
May 03, 2023
A bipartisan group of attorneys general from 23 states have joined a growing chorus calling on Medicare to reverse a previous decision and provide unrestricted coverage of Food and Drug Administration-approved...
Senators formulate plan to address chronic illness in Medicare beneficiaries
By
Lois A. Bowers
Oct 30, 2016
Improving health outcomes and reducing Medicare costs related to beneficiaries with chronic conditions such as Alzheimer’s disease, diabetes and heart disease are the goals of a bipartisan proposal...
Kim Campbell is on a memory care mission
By
Lois A. Bowers
Oct 02, 2017
Three years after Glen Campbell received his Alzheimer’s diagnosis, his wife, Kim, didn’t know that memory care communities existed. Now she’s on a mission to ensure that other family...
More news for Monday, Nov. 13
By
Kimberly Bonvissuto
Nov 13, 2023
CareTrust REIT moves forward with ‘foot on the gas’ … Assisted living community pays $59K in back wages, $7K in penalties for repeat wage violations … Coalition of business groups sues...
More news for Tuesday, Feb. 7
Feb 06, 2017
Search for Alzheimer’s drugs is more urgent than ever … How would Republican plans for Medicaid block grants actually work? … Long-term care advocates call on Canadian government to invest...
Older adults at risk for dementia see fast declines in household wealth before dementia onset
By
Kimberly Bonvissuto
Sep 19, 2023
Household wealth, especially financial wealth, declines much more quickly among people with probable dementia in the decade before dementia onset compared with older adults without a dementia diagnosis,...
38 senators call for more Alzheimer’s funding
By
Lois A. Bowers
Apr 16, 2018
Thirty-eight senators have asked leaders of the Senate Committee on Appropriations and its Subcommittee on Labor, Health and Human Services, and Education to make increased funding for Alzheimer’s...
2 ways to help residents combat dementia
Nov 19, 2015
Recently published research from the United States and Australian reveals two ways to slow or prevent cognitive decline.
Ethical considerations explored for aducanumab in Alzheimer’s disease
Nov 19, 2021
Grounds are insufficient to offer aducanumab (Aduhelm) for moderate, advanced Alzheimer’s dementia or for individuals without biomarker evidence of brain ß-amyloid, according to a position statement.
More news for Friday, April 8
By
Kimberly Bonvissuto
Apr 08, 2022
CBRE Seniors Housing & Care Investor Survey identifies industry trends … Senior housing staffing shortages move from severe to moderate: NIC … CMS finalizes Medicare coverage policy for Alzheimer’s...